New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Catalent, Inc.
CTLT
Shape
US Flag

NYSE

12B

Drug Manufacturers - Specialty & Generic

63.48USD

0.00 ( 0.00%)
Market Closed (as of Dec 17, 21:00 EDT)
favorite-chart

Relative Strenght

78
favorite-chart

Volume Buzz

503%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated March 20, 2025
1W % 1M % 3M % 1Y 13.66 %

Key Metrics

Shape
  • Market Cap

    11.52B


  • Shares Outstanding

    181.51M


  • Share in Float

    180.36M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    63.48


  • Average Volume

    2.27M


  • Beta

    1.158


  • Range

    42.11-63.5


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.catalent.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CTLT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape352%

2025-Revenue

$1.07

Shape251%

2025-EPS

$654M

Shape1068%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

RBC Capital

downgrade

Previous: Outperform

2024-02-06

Now: Sector Perform

Bernstein

upgrade

Previous: Not converted

2023-09-05

Now: Outperform

Susquehanna

upgrade

Previous: Not converted

2023-09-05

Now: Positive

UBS

downgrade

Previous: Not converted

2023-09-05

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-26%

0.67
vs 0.9

Q1.23

arrow
arrow

N/A

-0.09
vs 1.04

Q2.23

arrow
arrow

-92%

0.09
vs 1.19

Q3.23

arrow
arrow

N/A

-0.10
vs 0.34

Q4.23

arrow
arrow

N/A

-0.24
vs 0.67

Q1.24

arrow
arrow

N/A

-0.06
vs -0.09

Q2.24

arrow
arrow

+622%

0.65
vs 0.09

Q3.24

arrow
arrow

N/A

-0.13
vs -0.10

Q4.24

arrow
arrow

+154%

0.13
vs -0.24

Q1.25

arrow
arrow

+585%

0.29
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-6%

1.1B  vs 1.2B

Q1.23

arrow
arrow

-19%

1B  vs 1.3B

Q2.23

arrow
arrow

-19%

1.1B  vs 1.3B

Q3.23

arrow
arrow

-4%

982M  vs 1B

Q4.23

arrow
arrow

-11%

1B  vs 1.1B

Q1.24

arrow
arrow

+4%

1.1B  vs 1B

Q2.24

arrow
arrow

+22%

1.3B  vs 1.1B

Q3.24

arrow
arrow

+4%

1B  vs 982M

Q4.24

arrow
arrow

+8%

1.1B  vs 1B

Q1.25

arrow
arrow

+8%

1.2B  vs 1.1B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+2%

0.02
vs NA

Q1.23

arrow
arrow

-5%

-0.05
vs 0.02

Q2.23

arrow
arrow

-2%

-0.02
vs -0.05

Q3.23

arrow
arrow

-18%

-0.18
vs -0.02

Q4.23

arrow
arrow

-6%

-0.06
vs -0.18

Q1.24

arrow
arrow

-3%

-0.03
vs -0.06

Q2.24

arrow
arrow

+1%

0.01
vs -0.03

Q3.24

arrow
arrow

-4%

-0.04
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

561

561
vs 503

12%

Q2.23

arrow
arrow

490

490
vs 561

-13%

Q3.23

arrow
arrow

464

464
vs 490

-5%

Q4.23

arrow
arrow

445

445
vs 464

-4%

Q1.24

arrow
arrow

468

468
vs 445

5%

Q2.24

arrow
arrow

465

465
vs 468

-1%

Q3.24

arrow
arrow

490

490
vs 465

5%

Q4.24

arrow
arrow

8

8
vs 490

-98%

Earnings Growth

Latest News